Summary & Overview
CPT 3060F: Positive Microalbuminuria Test, Provider Documentation
CPT code 3060F denotes documentation and clinical review of a positive microalbuminuria (urine albumin) test, a marker of early kidney damage often seen in people with diabetes. Nationally, tracking and documenting microalbuminuria is important for early identification of diabetic nephropathy, risk stratification, and informing adjustments to diabetes treatment and renal-protective strategies.
Key payers covered in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis addresses how payers typically handle coverage and documentation expectations for positive microalbuminuria results and the provider actions that follow such findings.
Readers will find a concise clinical context for the test, typical sites of service, common modifiers and documentation elements associated with billing, and the operational implications for outpatient practices. The report highlights benchmarks for documentation prevalence, common payer considerations for acceptance of 3060F, and policy-related issues that affect coding consistency and quality measure reporting. Data not available in the input is clearly noted where appropriate.
Billing Code Overview
CPT code 3060F documents a positive microalbuminuria test where the provider records and reviews the presence of albumin in a urine sample. The result indicates albuminuria that may reflect kidney damage, commonly associated with diabetes, and may prompt changes in diabetes management.
Service type: Diagnostic laboratory test result review and clinical documentation
Typical site of service: Outpatient clinic or ambulatory care setting, including primary care and endocrinology visits where diabetes management is provided. If laboratory testing is performed off-site, the documentation and review still occur in the outpatient clinical encounter.
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with a 10-year history of type 2 diabetes presents for routine diabetes management in an outpatient primary care clinic. During the visit the nurse performs a random spot urine test for albumin (microalbuminuria). The result is positive for elevated albumin excretion. The provider reviews the test result, documents the positive 3060F finding in the medical record, assesses blood pressure and current antihyperglycemic regimen, and discusses potential implications for diabetic kidney disease. Based on the result the provider may order confirmatory testing (urine albumin-to-creatinine ratio), adjust antihypertensive or antidiabetic medications, refer to nephrology if indicated, and schedule follow-up monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
PN | Person Number — used to identify an individual involved in the service when required by payer rules | Use when payers require a person-specific modifier for reporting the performing individual on laboratory or outpatient services |
PO | Telehealth Originating Site Modifier (place of service) — indicates telehealth originating site in some payer systems | Use when the service is reported in conjunction with telehealth-related billing rules where is required by the payer for remote services